Clinical Trial

VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation in Patients With Heart Failure)

Study acronym: VINDICATE2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
VINDICATE 2 will be a randomised, placebo-controlled, parallel group, double-blind study of vitamin D versus placebo in otherwise optimally-managed patients with CHF due to LVSD and vitamin D deficiency (\<50nmol/L). The intervention will be a daily dose of 4000IU (100µg) per day or matching placebo for a minimum of 2 years and a maximum of 4 years.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-01-30; most recent amendment 2022-10-31.
Trial Details
NCT Number NCT03416361
Lead Sponsor University of Leeds
Conditions Chronic Heart Failure
Enrollment 1,253 participants
Start Date 2023-12-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2022-11-02